PEDIATRICS Vol. 103 No. 3 March 1999, pp. 588-593
The Effects of Valproate, Carbamazepine, and Oxcarbazepine on Growth and Sexual Maturation in Girls With Epilepsy
Received May 5, 1998; accepted Sep 8, 1998.
,,
From the Departments of * Neurology, Pediatrics, and
§ Radiology, University of Oulu, Oulu, Finland.
Objective. Antiepileptic drugs (AEDs) have endocrine effects that may interfere with growth and sexual maturation in children. The aim of this study was to evaluate the effects of AEDs on growth and pubertal development in girls with epilepsy.
Study Design. Forty girls taking valproate (VPA), 19 girls taking carbamazepine (CBZ), and 18 girls taking oxcarbazepine (OXC) for epilepsy and 49 healthy control girls participated in the study, which included a cross-sectional clinical examination when the girls were 8 to 18 years old and a longitudinal growth analysis from the age of 1 year.
Results. VPA, CBZ, or OXC did not affect linear growth or pubertal development in girls with epilepsy. However, the patients taking VPA gained weight, and an increase in relative weight was seen in girls who started their medication before as well as during puberty. The body mass index of the VPA-treated girls (19.8 ± 4.8 kg/m2) was higher than that of the control girls (18.0 ± 2.5 kg/m2) at clinical examination. The weight of the girls taking CBZ or OXC for epilepsy was similar to that of the control girls. Plasma insulin-like growth factor-I (IGF-I) levels were higher in girls treated with CBZ and OXC than in the control girls, but AEDs did not affect fasting serum insulin, IGF-binding protein-1, or IGF-binding protein-3 concentrations in girls on VPA, CBZ, or OXC medication during the period of exposure (average 2.8, 4.1, and 1.9 years, respectively) in this study.
Conclusions. AEDs do not seem to have any adverse effects on linear growth or sexual maturation in girls with epilepsy. VPA-related weight gain can be seen already in prepuberty and it is not associated with hyperinsulinemia in these young patients. The clinical significance of high circulating concentrations of IGF-I in patients taking CBZ or OXC remains to be defined. Key words: girls, epilepsy, antiepileptic drugs, growth, sexual maturation, insulin, insulin-like growth factor-I, insulin-like growth factor binding proteins -1 and -3.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Fedi, L. A. Bach, S. F. Berkovic, J. O. Willoughby, I. E. Scheffer, and D. C. Reutens Association of a Nicotinic Receptor Mutation with Reduced Height and Blunted Physostigmine-Stimulated Growth Hormone Release J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 634 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gungor, G. Yucel, A. Akinci, Y. Tabel, I. H. Ozerol, and S. Yologlu The Role of Ghrelin in Weight Gain and Growth in Epileptic Children Using Valproate J Child Neurol, December 1, 2007; 22(12): 1384 - 1388. [Abstract] [PDF]
|
|
|
|
 |
|
 B. J. Steinhoff Optimizing therapy of seizures in patients with endocrine disorders Neurology, December 26, 2006; 67(12_suppl_4): S23 - S27. [Abstract] [Full Text]
|
|
|
|
|
|
A. G. Herzog Menstrual disorders in women with epilepsy Neurology, March 28, 2006; 66(66_suppl_3): S23 - S28. [Abstract] [Full Text]
|
|
|
|
|
|
R. Sankar Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39. [Abstract] [Full Text]
|
|
|
|
|
|
K. Mikkonen, L. K. Vainionpaa, A. J. Pakarinen, M. Knip, I. Y. Jarvela, J. S. Tapanainen, and J. I. Isojarvi Long-term reproductive endocrine health in young women with epilepsy during puberty Neurology, February 10, 2004; 62(3): 445 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Nelson-DeGrave, J. K. Wickenheisser, J. E. Cockrell, J. R. Wood, R. S. Legro, J. F. Strauss III, and J. M. McAllister Valproate Potentiates Androgen Biosynthesis in Human Ovarian Theca Cells Endocrinology, February 1, 2004; 145(2): 799 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I.T. Isojarvi, E. Lofgren, K. S.T. Juntunen, A. J. Pakarinen, M. Paivansalo, I. Rautakorpi, and L. Tuomivaara Effect of epilepsy and antiepileptic drugs on male reproductive health Neurology, January 27, 2004; 62(2): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Tatum IV, J. Liporace, S. R. Benbadis, and P. W. Kaplan Updates on the Treatment of Epilepsy in Women Arch Intern Med, January 26, 2004; 164(2): 137 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wu, A. Legido, and F. De Luca Effects of Valproic Acid on Longitudinal Bone Growth J Child Neurol, January 1, 2004; 19(1): 26 - 30. [Abstract] [PDF]
|
|
|
|
 |
|
 T. M. Plant and M. L. Barker-Gibb Neurobiological mechanisms of puberty in higher primates Hum. Reprod. Update, January 1, 2004; 10(1): 67 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Noviasky, A. P. Porsteinsson, and Y. H. Lee Second Generation Anticonvulsant Medications: Their Use in Children The Journal of School Nursing, April 1, 2001; 17(2): 103 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rattya, J. Turkka, A. J. Pakarinen, M. Knip, M. A. Kotila, O. Lukkarinen, V.V. Myllyla, and J. I.T. Isojarvi Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy Neurology, January 9, 2001; 56(1): 31 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. T. Isojarvi and J. S. Tapanainen Valproate, Hyperandrogenism, and Polycystic Ovaries: A Report of 3 Cases Arch Neurol, July 1, 2000; 57(7): 1064 - 1068. [Abstract] [Full Text] [PDF]
|
|
